Oxygen therapy for acute myocardial infarction

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 12, 2016, Pages

  Cabello, Juan B ^a   Burls, Amanda ^b   Emparanza, José I ^c   Bayliss, Susan E ^d   Quinn, Tom ^e  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b CITY UNIVERSITY   (United Kingdom)

^c HOSPITAL DONOSTIA   (Spain)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN; AIR; ANALGESIC AGENT;

ACUTE HEART INFARCTION; BLEEDING; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HUMAN; META ANALYSIS; OXYGEN THERAPY; PAIN; PERICARDITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVASCULARIZATION; REVIEW; SYSTEMATIC REVIEW; ADVERSE EFFECTS; CAUSE OF DEATH; INTENTION TO TREAT ANALYSIS; MORTALITY; MYOCARDIAL INFARCTION; PAIN MEASUREMENT; PATHOLOGY; PROCEDURES;

AIR; ANALGESICS; CAUSE OF DEATH; HUMANS; INTENTION TO TREAT ANALYSIS; MYOCARDIAL INFARCTION; OXYGEN INHALATION THERAPY; PAIN MEASUREMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85006339759     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD007160.pub4     Document Type: Review

References (100)

1. Ranchord AM, Argyle R, Beynon R, Perrin K, Sharma V, Weatherall M, et al. High-concentration versus titrated oxygen therapy in ST-elevation myocardial infarction: a pilot randomized controlled trial. American Heart Journal 2012;163(2):168-75. [3034317]
2. Rawles J, Kenmure ACF. Controlled trial of oxygen in uncomplicated myocardial infarction. British Medical Journal 1976;1:1121-3. [3034319]
3. Nehme Z, Stub D, Bernard S, Stephenson M, Bray JE, Cameron P, et al. Effect of supplemental oxygen exposure on myocardial injury in ST-elevation myocardial infarction. Heart 2016;102(6):441-51. [4490706; DOI: 10.1136/heartjnl-2015-308636]
4. Smith K, Bernard S, Bray JE, Stephenson M, Cameron P, Meredith I, Kaye DM. A randomized controlled trial of oxygen therapy in acute myocardial infarction Air Verses Oxygen In myocarDial infarction study (AVOID Study). American Heart Journal 2012;169:339-45. [3034322]
5. Smith K, Bray J, Stub D, Stephenson M, Bernard S. Avoid methods and experience of initial randomisations. Academic Emergency Medicine 2012;19:762-3. [3034323]
6. Smith K, Nehme Z, Stub D, Stephenson M, Bernard S. Air Versus Oxygen In myocarDial infarction (AVOID) study: trial methods and experience from initial randomisation. Australasian Journal of Paramedicine 2012;10:24. [3034321]
7. Stub D, Smith K, Bernard S. A randomised controlled trial of oxygen therapy in acute ST-segment elevation myocardial infarction: the air versus oxygen in myocardial infarction (AVOID) study. Circulation 2014;130:2111. [3034324]
8. Stub D, Smith K, Bernard S, Nehme Z, Stephenson M, Bray J, et al. Air versus oxygen in myocardial infarction (AVOID) trial sub-study: time-dependent effect of oxygen administration on myocardial injury. Heart Lung and Circulation 2015;24(Suppl 3):S374. [4490707; DOI: 10.1016/j.hlc.2015.06.609]
9. Stub D, Smith K, Bernard S, et al. Air versus oxygen in ST-segment elevation myocardial infarction. Circulation 2015;131:2143-50. [3034325; DOI: 10.1161/CIRCULATIONAHA.114.014494]
10. Stub D. [pers comm]. RE: AVOID study. Juan Cabello 21 de July de 2015. [4490708]
11. Ukholkina GB, Kostianov II, Kuchkina NV, Grendo EP, Gofman I. Effect of oxygen therapy used in combination with reperfusion in patients with acute myocardial infarction. Kardiologiia 2005;45(5):59. [3034327]
12. Ukholkina GB, Kostyanov I, Kuchkina NV, Grendo EP, Gofman I. Oxygen therapy in combination with endovascular reperfusion during the first hours of acute myocardial infarction:clinical and laboratory findings. International Journal of Interventional Cardioangiology 2005;9:45-51. [3034328]
13. Wilson AT, Channer KS. Hypoxaemia and supplemental oxygen therapy in the first 24 hours after myocardial infarction: the role of pulse oximetry. Journal of the Royal College of Physicians of London 1997;31:657-61. [3034330]
14. Martin J, Shapiro T, Dixon S, Pensyl C, Oemrawsingh PV, Atsma D, et al. Aqueous oxygen therapy for ST-segment elevation myocardial infarction; AMIHOT trial safety report and enrolment completion. European Heart Journal 2004;25:422. [3034332]
15. Martin JL, Day F, Dixon S, Atsma D, Oemrawsingh P, Pensyl C, et al. Aqueous oxygen therapy for ST segment elevation myocardial infarction: AMIHOT trial safety report and enrolment completion. Journal of the American College of Cardiology 2004;43(5):304A. [3034333]
16. Martin JL, Day F, Dixon S, David S, Pensyl C, Hermiller J, et al. Aqueous oxygen therapy for ST-segment elevation myocardial infarction; AMIHOT trial design and interim report. American Journal of Cardiology 2003;92(6A):3L. [3034334]
17. Martin JL, Dixon S, David S, Pensyl C, Lindsay B, O'Neill W. Aqueous oxygen therapy for ST-segment elevation myocardial infarction: AMIHOT trial design and preliminary results. Journal of the American College of Cardiology 2003;41(6):72A. [3034335]
18. Martin JL, Oemrawsingh PV, Bartorelli AB, Dixon SD, Krukoff MW, Lindsay BS, et al. Aqueous oxygen therapy for ST segment elevation myocardial infarction; Final results and one year follow up of the AMIHOT trial. Journal of the American College of Cardiology 2005;45(3):242A. [3034336]
19. O'Neill WW, Martin JL, Dixon SR, Bartorelli AL, Trabattoni D, Oemrawsingh PV, et al. Acute myocardial infarction with hyperoxemic therapy (AMIHOT) - a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention. Journal of the American College of Cardiology 2007;50(5):397-405. [3034337]
20. Stone GW, Martin JL, De Boer MJ, Margheri M, Bramucci E, Blankenship JC, et al. Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction. Circulation. Cardiovascular interventions 2009;2(6):366-75. [3034338]
21. Dekleva M, Neskovic A, Vlahovic A, Putnikovic B, Beleslin B, Ostojic M. Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal 2004;148(4):E14. [3034340]
22. Dotsenko EA, Salivonchik DP, Kozyro VI. Long-term results of the use of hyperbaric oxygenation in patients with acute myocardial infarction. Kardiologiia 2007;47(12):53-6. [3034342]
23. Haude M. AMIHOT-II: A prospective, randomized evaluation of supersaturated oxygen therapy after percutaneous coronary intervention in acute anterior myocardial infarction. Herz 2007;32(8):669. [3034344]
24. Kerr F, Brown MG, Irving JB, Hoskins MR, Ewing DJ, Kirby BJ. A double-blind trial of patient-controlled nitrous-oxide/oxygen analgesia in myocardial infarction. Lancet 1975;1(7922):1397-400. [3034346]
25. Laden G. HOT MI pilot study. Hyperbaric oxygen and thrombolysis in myocardial infarction. American Heart Journal 1998;136(4 Pt 1):749. [3034348]
26. Shandling AH, Ellestad MH, Hart GB, Crump R, Marlow D, Van Natta B, et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the "HOT MI" pilot study. American Heart Journal 1997;134(3):544-50. [3034349]
27. Stavitsky Y, Shandling AH, Ellestad MH, Hart GB, Van Natta B, Messenger JC, et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomized multicenter study. Cardiology 1998;90(2):131-6. [3034350]
28. Slagboom T, De Winter R, Regar E, Schuler G, Thiele H, Laarman GJ, et al. Hemoglobin-based oxygen therapeutics in (elective) percutaneous (coronary) revascularization - The HEMOPURE trial. American Journal of Cardiology 2005;96(7A):51H. [3034352]
29. ACTRN12609000466246 A randomized controlled trial comparing controlled oxygen therapy versus high flow oxygen therapy for acute myocardial infarctions in the pre-hospital setting. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12609000466246 first received 23 May 2013. [3034354]
30. Khoshnood A, Carlsson A, Akbarzadeh M, Bhiladvala P, Roijer A, Hoglund P, et al. The effects of oxygen therapy on myocardial salvage in ST elevation myocardial infarction treated with acute percutaneous coronary intervention: the Supplemental Oxygen in Catheterized Coronary Emergency Reperfusion (SOCCER) study. Cardiology 2015;132:16-21. [3034356; DOI: 10.1159/000398786]
31. NCT01423929 Supplemental Oxygen in Catheterized Coronary Emergency Reperfusion (SOCCER). clinicaltrials.gov/show/NCT01423929 first received 23 May 2013. [3034357]
32. Hofmann R, James K, Svensson L, Witt N, Frick M, Lindahl B, et al. DETermination of the role of OXygen in Acute Myocardial Infarction (DETO2X-AMI trial). Scandinavian Cardiovascular Journal 2013;47:28. [3034360]
33. Hofmann R, James K, Svensson L, Witt N, Frick M, Lindahl B, et al. DETermination of the role of OXygen in suspected Acute Myocardial Infarction trial. American Heart Journal 2014;167:322-8. [3034361]
34. Hofmann R, Svensson L, Frick M, Jemberg T, James SK, Lindahl B, Ekelund U, Omerovic E, Herlitz J, Witt N. Determination of the role of oxygen in acute myocardial infarction (deto2x-ami) trial): safety and feasibility pilot study. Scandinavian Cardiovascular Journal. 2013; Vol. 47:28-9. [3034362]
35. NCT01787110 DETermination of the Role of OXygen in Suspected Acute Myocardial Infarction (DETO2X-AMI) Based on the SWEDEHEART Registry. clinicaltrials.gov/show/NCT01787110, 2013. [3034359]
36. NCT02290080 DETermination of the Role of OXygen in Suspected Acute Myocardial Infarction by Biomarkers (DETO2X-bio). clinicaltrials.gov/show/NCT02290080. [3034364]
37. Kallstrom TJ. American Association for Respiratory Care (AARC). AARC Clinical Practice Guideline: oxygen therapy for adults in the acute care facility--2002 revision & update. Respiratory Care 2002;47(6):717-20.
38. American Heart Association. American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care: part 8: stabilization of the patient with acute coronary syndromes. Circulation 2005;112 Suppl IV(24):89-110.
39. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al. ACC/AHA2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2007;116:e148-e304.
40. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary: a report of the American College of Cardiology/American Heart Association. Circulation 2004;110(5):588-636.
41. Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS, NRMI Investigators. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2005;294:448-54.
42. Barnes GD1, Katz A, Desmond JS, Kronick SL, Beach J, Chetcuti SJ, et al. False activation of the cardiac catheterization laboratory for primary PCI. American Journal of Managed Care 2013;19(8):671-5.
43. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. European Heart Journal 2007;28:1598-660.
44. Beasley R, Aldington S, Weatherall M, Robinson G, McHaffie D. Oxygen therapy in myocardial infarction: an historical perspective. Journal of the Royal Society of Medicine 2007;100(3):130-3.
45. Begg CB, Mazumdar M. Operating characteristics of rank correlation test for publication bias. Biometrics 1994;50:1088-101.
46. British Heart Foundation. Oxygen should not be routinely given to heart attack patients. www.bhf.org.uk/default.aspx?page=11843 (accessed 21 May 2013).
47. Cabello JB, Emparanza JI, Ruiz-Garcia V, Burls A. Oxygen therapy for acute myocardial infarction: a web-based survey of physicians' practices and beliefs [Oxigenoterapia en el infarto agudo de miocardio:una encuesta-web sobre la práctica y las creencias de los clínicos]. Emergencias 2009;21:422-8.
48. Capewell S, Beaglehole R, Seddon M, McMurray J. Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Circulation 2000;102(13):1511-6.
49. Chew DP, Aroney CN, Aylward PE, Kelly AM, White HD, Tideman PA, et al. 2011 Addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes (ACS). Heart, Lung & Circulation 2011;20:487-502.
50. Danchin N, Chemla D. Challenging doctors' lifelong habits may be good for their patients: oxygen therapy in acute myocardial infarction. Heart 2009;95(3):176-7.
51. Ecclestone TC1, Yeates DG, Goldacre MJ. Fall in population-based mortality from coronary heart disease negated in people with diabetes mellitus: data from England. Diabetic Medicine 2015;32(10):1329-34. [DOI: 10.1111/dme.12770]
52. Egger M, Smith GD, Shneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ 1997;315:629-34.
53. Farquhar H, Weatherall M, Wijesinghe M, Perrin K, Ranchord A, Simmonds M, Beasley R. Systematic review of studies of the effect of hyperoxia on coronary blood flow. Am Heart J 2009 Sep;158(3):371-7. [DOI: 10.1016/j.ahj.2009.05.037]
54. Goldberg RJ, Yarzebski J, Spencer FA, Zevallos JC, Lessard D, Gore JM. Thirty-year trends (1975-2005) in the magnitude, patient characteristics, and hospital outcomes of patients with acute myocardial infarction complicated by ventricular fibrillation. American Journal of Cardiology 2008;102:1595-601.
55. GRADE Working Group, McMaster University. GRADEpro. Version accessed prior to 12 December 2016. Hamilton (ON): GRADE Working Group, McMaster University, 2014.
56. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ, et al. GRADE Working Group. Rating quality of evidence and strength of recommendations: What is "quality of evidence" and why is it important to clinicians?. BMJ 2008;336(7651):995-8.
57. Higgins JPT, Thompson SJ, Deeks JJ, Altman DJ. Measuring inconsistencies in meta-analyses. BMJ 2003;327:557-60.
58. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
59. International Liaison Committee on Resuscitation. International Liaison Committee on Resuscitation Part 5: acute coronary syndromes. Resuscitation 2005;67(2-3):249-69.
60. Koopman C, Bots ML, Van Oeffelen AA, Van Dis I, Verschuren WM, Engelfriet PM, et al. Population trends and inequalities in incidence and short-term outcome of acute myocardial infarction between 1998 and 2007. International Journal of Cardiology 2013;168:993-8.
61. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
62. Mandelzweig L, Battler A, Boyko V, Beuno H, Danchin N, Fillipatos G, et al. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. European Heart Journal 2006;27(19):2285-93.
63. McCabe JM1, Armstrong EJ, Kulkarni A, Hoffmayer KS, Bhave PD, Garg S, et al. Prevalence and factors associated with false-positive ST-segment elevation myocardial infarction diagnoses at primary percutaneous coronary intervention-capable centers: a report from the Activate-SF registry. Archives of Internal Medicine 2012;172(11):864-71. [DOI: 10.1001/archinternmed.2012.945]
64. McNulty PH, King N, Scott S, Hartman G, McCann J, Kozak M, et al. Effects of supplemental oxygen administration on coronary blood flow in patients undergoing cardiac catheterization. American Journal of Physiology. Heart and Circulation Physiology 2005;288(3):H1057-62.
65. McNulty PH, Robertson BJ, Tulli MA, Hess J, Harach LA, Scott S, et al. Effect of hyperoxia and vitamin C on coronary blood flow in patients with ischaemic heart disease. Journal of Applied Physiology 2007;102(5):2040-5.
66. Milone SD, Newton GE, Parker JD. Hemodynamic and biochemical effects of 100% oxygen breathing in humans. Canadian Journal of Physiology and Pharmacology 1999;77(2):124-30.
67. Movahed MR, John J, Hashemzadeh M, Jamal MM, Hashemzadeh M. Trends in the age adjusted mortality from acute ST segment elevation myocardial infarction in the United States (1988-2004) based on race, gender, infarct location and co morbidities. American Journal of Cardiology 2009;104:1030.
68. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation 2015;131(4):e29-322. [DOI: 10.1161/CIR.0000000000000152]
69. Nedeljkovic ZS, Jacobs AK. O2 for STEMI: still up in the air. Circulation 2015;131(24):2101-3. [DOI: 10.1161/CIRCULATIONAHA.115.017072]
70. Nicholson C. A systematic review of the effectiveness of oxygen in reducing acute myocardial ischaemia. Journal of Clinical Nursing 2004;13(8):996-1007.
71. Nikolaou NI, Vrints CJ. Initial treatment of acute coronary syndromes. Is there a future for MONA acronym after the 2010 guidelines?. Resuscitation. 2012;83(1):e7.
72. O'Connor RE, Brady W, Brooks SC, Diercks G, Egan J, Ghaemmaghami C, et al. Part 10: acute coronary syndromes: 2010 American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2010;122(18 Suppl 3):S787-817.
73. O'Driscoll BR, Howard LS, Davison AG. BTS guideline for emergency oxygen use in adult patients. Thorax 2008;63 Suppl 6:1-68.
74. O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, De Lemos JA, et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. A report of the American College of Cardiology Foundation/American Heart Assoiation Task Force on Practice Guidelines. Journal of the American College of Cardiology 2013;61(4):e78-140.
75. Puymirat E1, Battler A, Birkhead J, Bueno H, Clemmensen P, Cottin Y, et al. Euro Heart Survey 2009 snapshot: regional variations in presentation and management of patients with AMI in 47 countries. European Heart Journal Acute Cardiovascular Care 2013;2(4):359-70. [DOI: 10.1177/2048872613497341]
76. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
77. Ripley DP1, Riley SJ, Shome JS, Awan MA, McCloskey MC, Murphy JJ, et al. Oxygen use for chest pain in coronary care units across the UK. QJM 2012;105(9):855-60.
78. Rousseau A, Bak Z, Janerot-Sjoberg B, Sjoberg F. Acute hyperoxemia-induced effects on regional blood flow, oxygen consumption and central circulation in man. Acta Physiologica Scandinavica 2005;183(3):231-40.
79. Russek HI, Regan FD, Naegele CF. One hundred percent oxygen in the treatment of acute myocardial infarction and severe angina pectoris. Journal of the American Medical Association 1950;50:2299-301.
80. Salzman HA. Efficacy of oxygen enriched gas mixtures in the treatment of acute myocardial infarction. Circulation 1975;52:357-9.
81. Schmidt M, Jacobsen JB, Lash TL, Bøtker HE, Sørensen HT. 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. BMJ 2012;344:e356.
82. Shuvy M, Atar D, Gabriel Steg P, Halvorsen S, Jolly S, Yusuf S, et al. Oxygen therapy in acute coronary syndrome: are the benefits worth the risk?. European Heart Journal 2013;34(22):1630-5.
83. Scottish Intercollegiate Guidelines Network. Acute coronary syndrome. A national clinical guideline. www.sign.ac.uk/pdf/sign93.pdf (accessed prior to 12 December 2016).
84. Scottish Intercollegiate Guidelines Network (SIGN). Acute coronary syndromes (SIGN publication no. 93). www.sign.ac.uk 2010 (accessed prior to 28 February 2013).
85. Smolina K, Wright FL, Rayner M, Goldacre MJ. Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study. BMJ 2012;344:d8059.
86. Steg PG, Dabbous OH, Feldman LJ, Cohen-Solal A, Aumont MC, López-Sendón J, et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation 2004;109:494-9.
87. Steg G, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, et al. Task force on the management of ST-elevation acute myocardial infarction of the European Cardiology Society (ESC). ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal 2012;33(20):2569-619.
88. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. European Heart Journal 2012;33(20):2551-67.
89. Townsend N, Nichols M, Scarborough P, Rayner M. Cardiovascular disease in Europe - epidemiological update 2015. European Heart Journal 2015;36(40):2696-705. [DOI: doi.org/10.1093/eurheartj/ehv428]
90. Van de Werf F, Bax J, Betriu A, Blömstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. European Heart Journal 2008;29(23):2909-45.
91. WHO 2011. Fact sheet N8310. www.who.int/mediacentre/factsheets/fs310/en/index.html (accessed prior to 30 June 2011).
92. Wijesinghe M, Perrin K, Ranchord A, Simmonds M, Weatherall M, Beasley R. Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart 2009;95(3):198-202.
93. Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008;336:601-5.
94. Xie LH, Chen F, Karagueuzian HS, Weiss JN. Oxidative-stress-induced after depolarizations and calmodulin kinase II signalling. Circulation Research 2009;104:79-86.
95. Yan AT, Steg PG, Fitzgerald G, Feldman LJ, Eagle KA, Gore JM, et al. Recurrent ischemia across the spectrum of acute coronary syndromes: Prevalence and prognostic significance of (Re-)infarction and ST-segment changes in a large contemporary registry. International Journal of Cardiology 2010; Vol. 145, issue 1:15-20.
96. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. New England Journal of Medicine 2010;362(23):2155-65.
97. Zughaft D, Bhiladvala P, Van Dijkman A, Harnek J, Madsen Hardig B, Bjork J, et al. The analgesic effect of oxygen during percutaneous coronary intervention (the OXYPAIN Trial). Acute Cardiology Care 2013;15:63-8.
98. Burls A, Cabello JB, Emparanza JI, Bayliss S, Quinn T. Oxygen therapy for acute myocardial infarction: a systematic review and meta-analysis. Emergency Medicine Journal 2011;28(11):917-23.
99. Cabello JB, Burls A, Emparanza JI, Bayliss S, Quinn T. Oxygen therapy for acute myocardial infarction. Cochrane Database of Systematic Reviews 2010, Issue 6. [DOI: 10.1002/14651858.CD007160.pub2]
100. Cabello JB, Burls A, Emparanza JI, Bayliss S, Quinn T. Oxygen therapy for acute myocardial infarction. Cochrane Database of Systematic Reviews 2013, Issue 8. [DOI: 10.1002/14651858.CD007160.pub3]